Enhanced recovery after microdiscectomy: reductions in opioid use, length of stay and cost

Background Enhanced recovery after surgery (ERAS) protocols are widely used worldwide. Recently, studies of the ERAS program in spinal surgery subspecialties have been reported. The aim of this study was to evaluate the impacts of ERAS in minimally invasive microdiscectomy (MD) surgery.Methods This was a retrospective cohort study of patients undergoing MD at a single center. From March 2018 to March 2021, 286 patients were in the ERAS group. A total of 140 patients from March 2017 to February 2018 were in the conventional group. The outcomes included length of stay (LOS), the postoperative numeric rating scale (NRS), complications, 30-day readmission rate, 30-day reoperation rate and cost. Moreover, perioperative factors were also evaluated.Results Compared with the conventional group, the LOS and cost were reduced in the ERAS group. There were no significant differences in the NRS, complication rate, 30-day readmission or reoperation rates between the groups. Furthermore, postoperative drainage volume, and postoperative opioid use were lower in the ERAS group.Conclusions The ERAS protocol for MD surgery reduces LOS, cost and opioid use and accelerates patient recovery.

Automated summary

This study aimed to evaluate the impacts of Enhanced recovery after surgery (ERAS) in minimally invasive microdiscectomy (MD) surgery. Compared to the conventional group, the ERAS group had reduced length of stay, cost, and opioid use, and accelerated patient recovery.